Quinolones as HCV NS5B polymerase inhibitors.
Kumar, D.V., Rai, R., Brameld, K.A., Somoza, J.R., Rajagopalan, R., Janc, J.W., Xia, Y.M., Ton, T.L., Shaghafi, M.B., Hu, H., Lehoux, I., To, N., Young, W.B., Green, M.J.(2011) Bioorg Med Chem Lett 21: 82-87
- PubMed: 21145235 
- DOI: 10.1016/j.bmcl.2010.11.068
- Primary Citation of Related Structures:  
3PHE, 3UDL - PubMed Abstract: 
Hepatitis C virus (HCV) infection is treated with a combination of peginterferon alfa-2a/b and ribavirin. To address the limitations of this therapy, numerous small molecule agents are in development, which act by directly affecting key steps in the viral life-cycle ...